NICE recommends treatment combination for advanced leukaemia
April 24, 2023Medical Communications
The National Institute for Health and Care Excellence (NICE) has recommended Janssen’s imbruvica (ibrutinib) alongside venetoclax as a treatment option …
Sanofi offers hepatitis A vaccine for UK children
April 24, 2023Medical Communications
Sanofi has introduced a hepatitis A vaccine for children aged between one to 15 years old in the UK. The …
AbbVie shares results from phase 3 trial for atogepant migraine treatment
April 24, 2023Research and Development
AbbVie has shared positive results from its phase 3 ELEVATE study, which assessed atogepant for the preventative treatment of episodic …
Aptar and Healint announce collaboration on CNS and immune system conditions management
April 24, 2023Medical Communications
AI healthcare company Healint and Software as a Medical Device (SaMD) expert Aptar Digital Health have announced a collaboration aiming …
RetinAI and Boehringer Ingelheim partner over AI treatments for geographic atrophy
April 21, 2023Medical Communications
Swiss data management software company RetinAI and US-based Boehringer Ingelheim have announced a partnership to improve patient outcomes in geographic …
FDA awards clearance to Meridian Bioscience for Curian Shiga Toxin assay
April 21, 2023Medical Communications
Meridian Bioscience, a US-based diagnostic testing solutions provider, has announced that the FDA has given clearance for its new Curian …
Breye Therapeutics Strengthens Management Team and Board
April 20, 2023Business Services
Copenhagen, Denmark, 20 April 2023 – Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing novel oral therapies for retinal …
Johnson & Johnson warns of dangers of Benadryl TikTok challenge
April 20, 2023Medical Communications
Following the death of a 13-year-old boy who took part in an online “challenge” to take a large amount of …
Eli Lilly partners with Ivy Tech Community College for scholarship programme
April 20, 2023Medical Communications
Eli Lilly and Ivy Tech Community College, Indiana, US, have announced a new scholarship programme, known as Lilly Scholars @ …
Trade union Unite calls for GSK staff walkouts over pay increase disputes
April 20, 2023Manufacturing and Production
UK-based trade union Unite is pushing for staff walkouts at several GSK manufacturing sites due to disputes regarding pay increases. …
PANTHERx Rare announces release of treatment for rare stable Wilson Disease
April 20, 2023Sales and Marketing
US-based rare medicines pharmacy PANTHERx Rare has announced the launch of Cuvrior, a treatment for stable Wilson Disease in adults …
Elsevier launches EmBiology to deliver the unparalleled insights into biological activities that accelerate drug discovery
April 19, 2023Business Services
New York, April 19, 2023 – Elsevier, a leader in global information analytics, has launched EmBiology, a research tool that …
Veeva MedTech Clinical Trials Report Signals Significant Opportunity to Improve Data Delivery and Quality
April 19, 2023Business Services
BARCELONA, Spain — 19 Apr. 2023 — Veeva Systems (NYSE: VEEV) today released its first-ever report examining global trends in …
Growth in global demand for pure medical cannabis sees Lesotho-based cultivator and manufacturer expand its production
April 19, 2023Business Services
19 April 2023, Maseru – Licensed cultivator and manufacturer of medical-grade cannabis extracts and products,
Revolo Biotherapeutics Announces Positive Topline Data from Phase 2a Trial of ‘1104 in Adults with Active Eosinophilic Esophagitis
April 19, 2023Business Services
NEW ORLEANS and CAMBRIDGE, UK, April 19 2023 – Revolo Biotherapeutics (“Revolo” or the “Company”), a company developing therapies that …
Engimmune Therapeutics appoints Dr. Lars Nieba as Chief Executive Officer
April 19, 2023Business Services
Basel, Switzerland, April 19, 2023. Engimmune Therapeutics AG (“Engimmune”), a Swiss biotech company developing novel T-cell receptor (TCR)-based therapeutics, today …
Oxford BioTherapeutics announces Phase 1b trial in collaboration with GORTEC to investigate OBT076 in Adenoid Cystic Carcinoma (ACC) of the head and neck
April 19, 2023Business Services
Oxford, UK and San Jose, Calif., 19 April 2023 – Oxford BioTherapeutics Ltd.
Acadia Pharmaceuticals announces commercialisation of Daybue for Rett syndrome
April 19, 2023Sales and Marketing
Acadia Pharmaceuticals has announced that Daybue (trofinetide) is now available for adult and paediatric patients over the age of two …
ANGLE and BioView partner to develop a CTC-based HER2 assay
April 19, 2023Medical Communications
ANGLE, a liquid biopsy company, and BioView, a company developing, manufacturing and marketing automated microscopy imaging and analysis solutions, have …
FDA issues update around changes to COVID-19 vaccines’ EUAs
April 19, 2023Medical Communications
The FDA has announced its amendment of the emergency use authorisations (EUAs) for the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
